FDA Briefing Document NDA 22529

First Page		Document Content
G protein coupled receptors Lorcaserin 5-HT2A receptor 5-HT2C receptor Agonist 5-HT2B receptor Ligand Anti-obesity medication Serotonin Biology Cell signaling Cell biology		FDA Briefing Document NDA 22529 Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 3,60 MB Share Document on Facebook

	SL-48. ApoE activators (agonist) Apolipoprotein E (ApoE) is secreted by astrocytes and regulates amyloid-β aggregation and clearance from the brain, reducing plaque burden and leading to enhanced cognition [1]. Expressi DocID: 1vc6E - View Document
	Aging Cell, pp872–884 Doi: acelLonger lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an a-glucosidase inhibitor or a DocID: 1uWH5 - View Document
	A narrow spectrum kinase inhibitor, RV1729, induces bronchodilation of human small airways and rescues agonist-induced desensitization of the β2 adrenoreceptor (β2AR) 1 Koziol-White , 1 DocID: 1tLjU - View Document
	ABSTRACT Calcium-permeable cation channels of the transient receptor potential (TRP) superfamily are involved in agonist-induced calcium influx in several cell types. In this work we evaluated expression and localisatio DocID: 1tamv - View Document
	A Phase I Study of tohe oll-‐like Receptor 5 Agonist, DocID: 1taaw - View Document